Kaskela Law LLC is investigating 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) (“4D Molecular”) on behalf of the company’s stockholders.

Since March 2024, shares of 4D Molecular’s stock have declined from a trading price of over $34.00 per share to a current price of under $17.00 per share, a decline of 50% in value.

The investigation seeks to determine whether 4D Molecular and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s investors.

4D Molecular shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, for additional information about this investigation and their legal rights and options.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750